SG11201703557UA - Six-membered ring benzo derivatives as dpp-4 inhibitor and use thereof - Google Patents
Six-membered ring benzo derivatives as dpp-4 inhibitor and use thereofInfo
- Publication number
- SG11201703557UA SG11201703557UA SG11201703557UA SG11201703557UA SG11201703557UA SG 11201703557U A SG11201703557U A SG 11201703557UA SG 11201703557U A SG11201703557U A SG 11201703557UA SG 11201703557U A SG11201703557U A SG 11201703557UA SG 11201703557U A SG11201703557U A SG 11201703557UA
- Authority
- SG
- Singapore
- Prior art keywords
- dpp
- inhibitor
- membered ring
- benzo derivatives
- ring benzo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/08—Naphthothiopyrans; Hydrogenated naphthothiopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410609270 | 2014-10-31 | ||
PCT/CN2015/093384 WO2016066134A1 (zh) | 2014-10-31 | 2015-10-30 | 作为dpp-4抑制剂的苯并六元环衍生物及其应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201703557UA true SG11201703557UA (en) | 2017-06-29 |
Family
ID=55856635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201703557UA SG11201703557UA (en) | 2014-10-31 | 2015-10-30 | Six-membered ring benzo derivatives as dpp-4 inhibitor and use thereof |
Country Status (12)
Country | Link |
---|---|
US (1) | US10479798B2 (da) |
EP (1) | EP3214079B1 (da) |
JP (1) | JP6731917B2 (da) |
KR (1) | KR102637487B1 (da) |
CN (1) | CN105566276B (da) |
AU (1) | AU2015341177B2 (da) |
BR (1) | BR112017009012B1 (da) |
CA (1) | CA2966250C (da) |
DK (1) | DK3214079T3 (da) |
RU (1) | RU2702644C2 (da) |
SG (1) | SG11201703557UA (da) |
WO (1) | WO2016066134A1 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107266373A (zh) * | 2017-08-01 | 2017-10-20 | 安徽拜善晟制药有限公司 | 一种原料药达沙布韦的制备方法 |
CN107899073B (zh) * | 2017-12-27 | 2021-03-30 | 北京大学第一医院 | 骨水泥、其制备方法和用途 |
CN110237068A (zh) * | 2018-03-09 | 2019-09-17 | 山东百极地长制药有限公司 | 苯并六元环衍生物作为dpp-4长效抑制剂的应用 |
CN110240586B (zh) * | 2018-03-09 | 2023-01-24 | 山东百极地长制药有限公司 | 2,3-二氢-1H-苯并[f]色满-2-胺衍生物的制备方法 |
CN110372663A (zh) * | 2018-04-13 | 2019-10-25 | 山东百极地长制药有限公司 | 含硫杂环化合物及其作为dpp4抑制剂衍生物的应用 |
CN113801087B (zh) * | 2020-06-12 | 2024-08-30 | 山东百极地长制药有限公司 | 作为dpp-4抑制剂的苯并六元环衍生物及其应用 |
CN113801088B (zh) * | 2020-06-12 | 2024-04-26 | 山东百极地长制药有限公司 | 苯并六元环衍生物及其应用 |
CN115611843A (zh) * | 2021-07-15 | 2023-01-17 | 山东百极地长制药有限公司 | 一种dpp4抑制活性化合物的多晶型及其制备方法 |
CN115611842A (zh) * | 2021-07-15 | 2023-01-17 | 山东百极地长制药有限公司 | 一种dpp4抑制活性化合物的多晶型及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US721388A (en) * | 1902-07-15 | 1903-02-24 | George E Pratt | Breast-collar. |
US1228538A (en) * | 1916-04-18 | 1917-06-05 | Walter E Dennison | Process of manufacturing architectural terra-cotta in colors for building purposes and the product of such process. |
US1279894A (en) * | 1917-07-09 | 1918-09-24 | Western Electric Co | Telephone-receiver. |
TW200806669A (en) | 2006-03-28 | 2008-02-01 | Merck & Co Inc | Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes |
WO2008097976A1 (en) | 2007-02-09 | 2008-08-14 | Kalypsys, Inc. | Heterocyclic modulators of tgr5 for treatment of disease |
EP3872071A1 (en) * | 2013-04-04 | 2021-09-01 | Sphaera Pharma Pvt. Ltd. | Novel analogues of epicatechin and related polyphenols |
-
2015
- 2015-10-30 EP EP15855852.8A patent/EP3214079B1/en active Active
- 2015-10-30 AU AU2015341177A patent/AU2015341177B2/en active Active
- 2015-10-30 RU RU2017117559A patent/RU2702644C2/ru active
- 2015-10-30 SG SG11201703557UA patent/SG11201703557UA/en unknown
- 2015-10-30 CN CN201510730799.4A patent/CN105566276B/zh active Active
- 2015-10-30 CA CA2966250A patent/CA2966250C/en active Active
- 2015-10-30 BR BR112017009012-0A patent/BR112017009012B1/pt active IP Right Grant
- 2015-10-30 JP JP2017523808A patent/JP6731917B2/ja active Active
- 2015-10-30 US US15/523,058 patent/US10479798B2/en active Active
- 2015-10-30 KR KR1020177014842A patent/KR102637487B1/ko active IP Right Grant
- 2015-10-30 DK DK15855852.8T patent/DK3214079T3/da active
- 2015-10-30 WO PCT/CN2015/093384 patent/WO2016066134A1/zh active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US10479798B2 (en) | 2019-11-19 |
CA2966250C (en) | 2023-10-10 |
AU2015341177B2 (en) | 2019-01-03 |
KR20170106294A (ko) | 2017-09-20 |
EP3214079A1 (en) | 2017-09-06 |
RU2017117559A3 (da) | 2018-11-30 |
KR102637487B1 (ko) | 2024-02-19 |
EP3214079B1 (en) | 2020-06-24 |
RU2017117559A (ru) | 2018-11-30 |
BR112017009012B1 (pt) | 2022-10-18 |
WO2016066134A1 (zh) | 2016-05-06 |
CN105566276A (zh) | 2016-05-11 |
EP3214079A4 (en) | 2018-03-28 |
BR112017009012A2 (pt) | 2017-12-26 |
US20170313715A1 (en) | 2017-11-02 |
JP2017533226A (ja) | 2017-11-09 |
JP6731917B2 (ja) | 2020-07-29 |
DK3214079T3 (da) | 2020-09-28 |
CN105566276B (zh) | 2021-01-08 |
AU2015341177A1 (en) | 2017-05-25 |
CA2966250A1 (en) | 2016-05-06 |
RU2702644C2 (ru) | 2019-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181650T1 (hr) | Biciklički heterociklički derivati kao inhibitori bromodomene | |
SG11201703557UA (en) | Six-membered ring benzo derivatives as dpp-4 inhibitor and use thereof | |
IL251988A0 (en) | Compounds acting on glycans and methods of using them | |
IL252560B (en) | Heterocyclic derivatives and their uses | |
EP3154972A4 (en) | Azamophinan derivatives and use thereof | |
SI3089971T1 (sl) | Spojine in postopki za uporabo | |
PT3159344T (pt) | Derivado em anel aminopiranoide e sua composição e utilização | |
PL3162804T3 (pl) | Nowa pochodna benzodiazepiny i jej zastosowanie | |
ZA201704462B (en) | New benzimidazole derivatives as antihistamine agents | |
EP3197885A4 (en) | Heterocyclic compounds and use thereof | |
EP3194377A4 (en) | Heterocycle substituted amino-pyridine compounds and methods of use thereof | |
SG11201605915WA (en) | Furo-3-carboxamide derivatives and methods of use | |
HK1250028A1 (zh) | 2-苯基-6-咪唑基-吡啶-4-甲酰胺衍生物及其作為eaat3抑制劑的用途 | |
ZA201606450B (en) | Compounds and their methods of use | |
IL261645A (en) | History of dioxo-hexahydroisoindolyl and their use as cyclophilin inhibitors | |
EP3526216C0 (en) | BENZOTHIAZOLE DERIVATIVES AS DYRK1 INHIBITORS | |
GB201416351D0 (en) | Heterocyclic derivatives | |
ZA201705100B (en) | Jasmonate derivatives and compositions thereof | |
GB201403697D0 (en) | Compounds and methods of use | |
GB201415969D0 (en) | Pharmaceutical compositions comprising of hetero-bicyclic derivatives, and methods of use thereof | |
AU2014901768A0 (en) | Heterocyclic compounds and use of same | |
PT3165222T (pt) | Utilização do composto de ftalida |